Etanercept Drug Level ELISA (IDKmonitor®)

Product code: K9646 (96 wells)

Determination of free therapeutic etanercept

The innovative IDKmonitor Etanercept Drug Level ELISA is a microplate-based assay that allows quantitative determination of free etanercept from plasma or serum samples. Etanercept is a human therapeutic monoclonal antibody (mAb) used to monitor treatment for chronic rheumatic diseases such as rheumatoid arthritis. This test is intended to quantify the amount of free etanercept to evaluate its efficacy, as well as to investigate primary non-response, loss of response and non-remission, giving the treating clinician an opportunity to monitor and optimise therapy.

Key Advantages

Highly specific assay, with no cross reactivity with infliximab, adalimumab or golimumab
Quick and reliable, with a total incubation time of 130 minutes
Gastroenterology and rheumatology applications
Reportable range 0.14-11.25 ug/ml
Easily automated on ELISA automates, such as the Dynex DS2

Specifications

ELISA

40 tests

Storage: 2-8 °C

Blood sample


Related Products

    Etanercept Free Anti-drug Antibody ELISA (IDKmonitor®)

    IDKmonitor Etanercept Free Anti-drug Antibody ELISA is a quantitative assay that detects human antibodies against etanercept in EDTA plasma and serum samples. Etanercept is a human therapeutic monoclonal antibody used to monitor treatment for chronic rheumatic diseases such as rheumatoid arthritis.